The American Medical Association and the AARP issue briefs in defense of the Affordable Care Act (ACA), while President Trump is delaying an ACA alternative until after the 2020; top hospitals offer unproven stem cell treatments; the measles outbreak hits a new high.
The American Medical Association (AMA) and the AARP (formerly the American Association of Retired Persons) filed amicus briefs in the case of Texas v. United States, according to statements from the AMA and the AARP. Meanwhile, President Trump is delaying an ACA alternative until after the 2020 election, according to The New York Times.
A growing number of well-regarded hospitals are pursuing stem cell treatments and related therapies such as platelet injections, reported Kaiser Health News. The treatments, aimed at treating joint pain without surgery,include injecting patients’ joints with their own fat or bone marrow cells. However, the evidence supporting the costly therapies has been lacking, Kaiser said.
More people have contracted measles in the first 3 months of 2019 than throughout the entire year of 2018, The Washington Post reported. This year marks the second highest number of cases reported since US health officials declared the disease “eliminated” 19 years ago. There have been a total of 387 cases reported, spurring from a decrease in child immunizations as a result of from misinformation about the safety of vaccines.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
What We’re Reading: Affordable Home Care; Mycoplasma Infections Rise; Opioid Crisis Settlement
December 4th 2023Families struggle to find affordable, reliable home health aides; reports of increased pediatric pneumonia cases; legal battle ensues over Purdue Pharma’s bankruptcy settlement.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
New Data Update Myasthenia Gravis Outcomes for Patients in Australia
December 3rd 2023Patients living with myasthenia gravis in Australia were surveyed their demographic information, clinical features of the autoimmune disease, adverse effects from treatment, and quality of life. Outcomes were compared against 2011 data from Australia and 2019 data from the United States.
Read More
NK Cell Therapy SNK01 Improves Cognitive Function in Alzheimer Disease for up to 11 Weeks
December 3rd 2023Among 10 patients evaluated, compared with their baseline at 1 week after receiving their final dose in the trial, 30% demonstrated clinical improvement on the Alzheimer’s disease composite score.
Read More